| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.001 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.001 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |